Showing results (921-930 of 1,104) with videos related to

Sort By:
Pageof 111
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2011
A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinomaA J Zurita, E Jonasch, X Wang, et al.
Cancer Research Communications|November 6, 2023
Monitoring Glucocorticoid Receptor in Plasma-derived Extracellular Vesicles as a Marker of Resistance to Androgen Receptor Signaling Inhibition in Prostate CancerEmanuela Gentile, Andrew W Hahn, Jian H Song, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 5, 2014
Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinicLydia T Madsen, Deborah A Kuban, Seungtaek Choi, et al.
Cancer Chemotherapy and Pharmacology|July 22, 2017
Clinical predictors of survival in patients with castration-resistant prostate cancer receiving sipuleucel-T cellular immunotherapyMehmet Asim Bilen, Kenneth R Hess, Sumit K Subudhi, et al.
The Journal of Biological Chemistry|January 19, 2020
The small molecule GAT1508 activates brain-specific GIRK1/2 channel heteromers and facilitates conditioned fear extinction in rodentsYu Xu, Lucas Cantwell, Andrei I Molosh, et al.
Molecular Cancer Research : MCR|September 16, 2022
Subtype and Site Specific-Induced Metabolic Vulnerabilities in Prostate CancerFederica Mossa, Daniele Robesti, Ramachandran Sumankalai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 14, 2011
Modeling a lethal prostate cancer variant with small-cell carcinoma featuresVassiliki Tzelepi, Jiexin Zhang, Jing-Fang Lu, et al.
Molecular Cancer Research : MCR|August 19, 2008
Cadherin-11 promotes the metastasis of prostate cancer cells to boneKhoi Chu, Chien-Jui Cheng, Xiangcang Ye, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 13, 2015
Selection and identification of ligand peptides targeting a model of castrate-resistant osteogenic prostate cancer and their receptorsJami Mandelin, Marina Cardó-Vila, Wouter H P Driessen, et al.
Cancer Research|May 21, 2010
Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblastsChih-Fen Huang, Cristina Lira, Khoi Chu, et al.
Pageof 111